Article Details

ABVC BioPharma Provides ADHD Phase II Part 2 Clinical Update - GlobeNewswire

Retrieved on: 2022-07-13 12:45:20

Tags for this article:

Click the tags to see associated articles and topics

ABVC BioPharma Provides ADHD Phase II Part 2 Clinical Update - GlobeNewswire. View article details on hiswai: https://www.globenewswire.com/news-release/2022/07/13/2478991/0/en/ABVC-BioPharma-Provides-ADHD-Phase-II-Part-2-Clinical-Update.html

Excerpt

FREMONT, CA, July 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company.

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up